Harbour Investments’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Harbour Investments's LLY Position: Q1 2026 in Review
Harbour Investments increased its Eli Lilly (LLY) stake by 2.7% in Q1 2026, buying an estimated $729K and bringing the position to 27,501 shares worth $25.3M. The position accounts for 0.39% of the portfolio, ranked #48.
Harbour Investments first reported a position in LLY in Q1 2021 and has held it in 20 quarters since. The position peaked at $28.8M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Harbour Investments held 27,501 shares of Eli Lilly worth $25.3M as of Q1 2026.
- Harbour Investments bought 719 Eli Lilly shares in Q1 2026, an estimated $729K.
- Eli Lilly made up 0.39% of Harbour Investments's portfolio in Q1 2026, its #48 holding.
- Harbour Investments first reported a position in Eli Lilly in Q1 2021 and has held it in 20 quarters since.
- Harbour Investments's Eli Lilly position peaked at $28.8M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.